Next Article in Journal
Formulation-by-Design of Efinaconazole Spanlastic Nanovesicles for Transungual Delivery Using Statistical Risk Management and Multivariate Analytical Techniques
Previous Article in Journal
Isolation and Molecular Characterization of a Novel Lytic Bacteriophage That Inactivates MDR Klebsiella pneumoniae Strains
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(7), 1420; https://doi.org/10.3390/pharmaceutics14071420
Action Date Notes Link
article pdf uploaded. 6 July 2022 14:37 CEST Version of Record https://www.mdpi.com/1999-4923/14/7/1420/pdf-vor
article supplementary file uploaded. 6 July 2022 14:37 CEST - https://www.mdpi.com/1999-4923/14/7/1420#supplementary
article xml file uploaded 7 July 2022 11:37 CEST Original file -
article xml uploaded. 7 July 2022 11:37 CEST Update -
article pdf uploaded. 7 July 2022 11:37 CEST Updated version of record https://www.mdpi.com/1999-4923/14/7/1420/pdf-vor
article html file updated 7 July 2022 11:38 CEST Original file -
article xml file uploaded 7 July 2022 12:24 CEST Update -
article xml uploaded. 7 July 2022 12:24 CEST Update -
article pdf uploaded. 7 July 2022 12:24 CEST Updated version of record https://www.mdpi.com/1999-4923/14/7/1420/pdf-vor
article html file updated 7 July 2022 12:26 CEST Update -
article xml file uploaded 21 July 2022 08:29 CEST Update -
article xml uploaded. 21 July 2022 08:29 CEST Update https://www.mdpi.com/1999-4923/14/7/1420/xml
article pdf uploaded. 21 July 2022 08:29 CEST Updated version of record https://www.mdpi.com/1999-4923/14/7/1420/pdf
article html file updated 21 July 2022 08:31 CEST Update -
article html file updated 13 August 2022 00:30 CEST Update https://www.mdpi.com/1999-4923/14/7/1420/html
Back to TopTop